Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
TC Biopharm
TC Biopharm
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Optimising RNA production for faster and cheaper pharmaceutical manufacturing
RNA production can be a lengthy and complex process, but the Ntensify platform could change this by diminishing development times, decreasing production costs and allowing the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Owlstone Medical bags $6.5m to optimise infectious disease diagnostic tool
The Bill & Melinda Gates Foundation has funded the bolstering of the Breath Biopsy platform, as well as research into breath biomarkers in tuberculosis (TB) and HIV
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Pharmaceutical
Collaboration to develop gamma delta CAR T cell product candidates
bluebird bio and Scottish immunotherapy company TC BioPharm, announced a strategic collaboration and license agreement focused on gamma delta CAR T cells
Pharmaceutical
TC BioPharm acquires more production space in Glasgow, UK
The pioneering biotechnology company has trebled its space at the Maxin Office Park due to business growth
Design & Build
WH Partnership completes cancer facility for TC BioPharm in Glasgow
Facility receives MHRA licence to manufacture human cell therapy products
Design & Build
TC BioPharm completes construction of its Clinical Manufacturing Facility
Two cleanrooms and office facilities have been built at Maxim Park, Glasgow
Research & Development
TC BioPharm to develop cancer treatment with Medinet of Japan
Supported by £500,000 Regional Selective Assistance
Subscribe now